Cargando…
Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective
High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824829/ https://www.ncbi.nlm.nih.gov/pubmed/29460707 http://dx.doi.org/10.1177/2472555217744728 |
_version_ | 1783302091915132928 |
---|---|
author | Rainard, Julie M. Pandarakalam, George C. McElroy, Stuart P. |
author_facet | Rainard, Julie M. Pandarakalam, George C. McElroy, Stuart P. |
author_sort | Rainard, Julie M. |
collection | PubMed |
description | High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques. |
format | Online Article Text |
id | pubmed-5824829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58248292018-03-08 Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective Rainard, Julie M. Pandarakalam, George C. McElroy, Stuart P. SLAS Discov Review High-throughput screening (HTS) is a proven method for discovering new lead matter for drug discovery and chemical biology. To maximize the likelihood of identifying genuine binders to a molecular target, and avoid wasting resources following up compounds with unproductive/nonspecific mechanisms of action, it is important to employ a range of assays during an HTS campaign that build confidence of target engagement for hit compounds. Biophysical methods that measure direct target/compound engagement have established themselves as key techniques in generating this confidence, and they are now integral to the latter stages of HTS triage at the European Lead Factory (ELF). One relatively new technique that the ELF is using is microscale thermophoresis (MST), which measures the differences in rate of movement through a temperature gradient that are caused when single molecular species form complexes. Here we provide an overview of the MST assay development workflow that the ELF employs and a perspective of our experience to date of using MST to triage the output of HTS campaigns and how it compares and contrasts with the use of other biophysical techniques. SAGE Publications 2018-02-20 2018-03 /pmc/articles/PMC5824829/ /pubmed/29460707 http://dx.doi.org/10.1177/2472555217744728 Text en © 2017 Society for Laboratory Automation and Screening http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Rainard, Julie M. Pandarakalam, George C. McElroy, Stuart P. Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title | Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title_full | Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title_fullStr | Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title_full_unstemmed | Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title_short | Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective |
title_sort | using microscale thermophoresis to characterize hits from high-throughput screening: a european lead factory perspective |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824829/ https://www.ncbi.nlm.nih.gov/pubmed/29460707 http://dx.doi.org/10.1177/2472555217744728 |
work_keys_str_mv | AT rainardjuliem usingmicroscalethermophoresistocharacterizehitsfromhighthroughputscreeningaeuropeanleadfactoryperspective AT pandarakalamgeorgec usingmicroscalethermophoresistocharacterizehitsfromhighthroughputscreeningaeuropeanleadfactoryperspective AT mcelroystuartp usingmicroscalethermophoresistocharacterizehitsfromhighthroughputscreeningaeuropeanleadfactoryperspective |